Israel Englander Paratek Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.37 - $2.54 $681,024 - $1.26 Million	-497,098 Reduced 87.43%	71,470 $182,000
Q4 2022 Feb 14, 2023	BUY	$1.67 - $2.51 $458,363 - $688,917	274,469 Added 93.33%	568,568 $1.06 Million
Q3 2022 Nov 14, 2022	SELL	$1.96 - $2.93 $411,839 - $615,657	-210,122 Reduced 41.67%	294,099 $756,000
Q2 2022 Aug 15, 2022	BUY	$1.73 - $3.09 $598,666 - $1.07 Million	346,050 Added 218.78%	504,221 $973,000
Q1 2022 May 16, 2022	BUY	$2.94 - $4.77 $465,022 - $754,475	158,171 New	158,171 $470,000
Q4 2021 Feb 14, 2022	SELL	$4.07 - $5.3 $90,813 - $118,258	-22,313 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$4.7 - $7.24 $1.07 Million - $1.65 Million	-227,472 Reduced 91.07%	22,313 $108,000
Q2 2021 Aug 16, 2021	BUY	$6.81 - $10.93 $1.7 Million - $2.73 Million	249,785 New	249,785 $1.7 Million
Q3 2020 Nov 16, 2020	SELL	$4.19 - $6.69 $48,717 - $77,784	-11,627 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$2.97 - $5.22 $14,695 - $25,828	-4,948 Reduced 29.85%	11,627 $61,000
Q1 2020 May 14, 2020	SELL	$2.67 - $4.97 $45,913 - $85,464	-17,196 Reduced 50.92%	16,575 $52,000
Q4 2019 Feb 14, 2020	BUY	$2.93 - $4.5 $98,949 - $151,969	33,771 New	33,771 $136,000
Q2 2019 Aug 14, 2019	SELL	$3.47 - $6.32 $727,867 - $1.33 Million	-209,760 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$5.36 - $7.24 $1.12 Million - $1.52 Million	209,760 New	209,760 $1.12 Million
Q4 2018 Feb 14, 2019	SELL	$4.8 - $11.6 $68,548 - $165,659	-14,281 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$9.05 - $10.95 $915,923 - $1.11 Million	-101,207 Reduced 87.63%	14,281 $139,000
Q2 2018 Aug 14, 2018	BUY	$10.2 - $13.9 $336,436 - $458,477	32,984 Added 39.98%	115,488 $1.18 Million
Q1 2018 May 15, 2018	SELL	$12.65 - $18.85 $2.7 Million - $4.02 Million	-213,118 Reduced 72.09%	82,504 $1.07 Million
Q4 2017 Feb 14, 2018	SELL	$17.45 - $25.6 $675,855 - $991,513	-38,731 Reduced 11.58%	295,622 $5.29 Million
Q3 2017 Nov 14, 2017	BUY	$18.9 - $28.2 $6.32 Million - $9.43 Million	334,353	334,353 $8.39 Million

Others Institutions Holding PRTK

# of Institutions

Shares Held

1.54M

Call Options Held

Put Options Held

View Full List

About Paratek Pharmaceuticals, Inc.

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

More about PRTK

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account